PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
Abstract
Share and Cite
Bunse, T.; Kosinska, A.D.; Michler, T.; Protzer, U. PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B. Biomolecules 2022, 12, 470. https://doi.org/10.3390/biom12030470
Bunse T, Kosinska AD, Michler T, Protzer U. PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B. Biomolecules. 2022; 12(3):470. https://doi.org/10.3390/biom12030470
Chicago/Turabian StyleBunse, Till, Anna D. Kosinska, Thomas Michler, and Ulrike Protzer. 2022. "PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B" Biomolecules 12, no. 3: 470. https://doi.org/10.3390/biom12030470
APA StyleBunse, T., Kosinska, A. D., Michler, T., & Protzer, U. (2022). PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B. Biomolecules, 12(3), 470. https://doi.org/10.3390/biom12030470